U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918404) titled 'Safety and Tolerability of Fluticasone Propionate 10% Nasal Insert in Participants With Chronic Allergic Rhinitis' on Oct. 23.
Brief Summary: Phase 1 study designed to evaluate the safety, tolerability and Pharmacokinetic (PK) of a fluticasone propionate (FP) 10% nasal insert in adults suffering from persistent allergic rhinitis. The nasal insert is intended to deliver FP locally. The study will consist of a 4-week treatment period (Main Phase) followed by a 22-week follow-up period (Extension Phase).
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Allergic Rhinitis
Intervention:
DRUG: Fluticasone Pro...